Pharma Mar, S.A. (BME:PHM)

ATSG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.59	63.24	60.02	149.81	113.35	96.21
Short-Term Investments	106.49	91.29	102.54	32.61	88.53	99.31
Cash & Short-Term Investments	128.08	154.53	162.56	182.42	201.88	195.52
Cash Growth	-5.23%	-4.94%	-10.89%	-9.64%	3.26%	835.71%
Accounts Receivable	59.91	34.27	27.2	29.32	50.91	24.05
Other Receivables	-	0.41	0.35	-	-	-
Receivables	59.91	34.68	27.55	29.32	50.91	24.05
Inventory	51.48	50.89	39.29	27.75	10.54	11.93
Prepaid Expenses	1.98	1.74	2.92	5.98	3.91	1
Other Current Assets	7.96	8.41	20.28	29.71	28	13.15
Total Current Assets	249.4	250.25	252.6	275.18	295.23	245.65
Property, Plant & Equipment	57.68	57.75	34.54	33.23	26.9	24.75
Long-Term Investments	0.82	2.46	6.06	49.4	10.72	20.99
Other Intangible Assets	1.12	1	1.23	1.19	1.13	0.99
Long-Term Deferred Tax Assets	38.38	36.01	31.47	30.53	27.75	33.42
Long-Term Deferred Charges	-	-	0.7	1.4	2.11	2.81
Other Long-Term Assets	0.85	2.18	13.91	2.33	4.55	1.67
Total Assets	348.25	349.64	340.52	393.26	368.39	330.26
Accounts Payable	46.82	38.81	29.17	27.49	26.93	21.04
Accrued Expenses	3.03	13.57	12.39	10.44	9.5	8.79
Short-Term Debt	-	4.72	6.46	4.48	3.84	4.77
Current Portion of Long-Term Debt	10.76	3.25	6.37	8.64	8.37	10.54
Current Portion of Leases	1.73	1.88	1.98	1.61	1.82	1.47
Current Unearned Revenue	5.32	5.38	25.93	26.11	30.89	44.71
Other Current Liabilities	20.13	15.08	13.59	18.54	4.99	3.61
Total Current Liabilities	87.78	82.69	95.89	97.32	86.35	94.92
Long-Term Debt	37.57	39.87	27.04	25.88	33.39	37.73
Long-Term Leases	1.34	1.36	1.83	2.01	1.92	2.15
Long-Term Unearned Revenue	19.83	17.17	22.14	44.9	68.63	92.56
Other Long-Term Liabilities	0.2	0.19	0.19	0.19	0.19	0.18
Total Liabilities	146.72	141.29	147.08	170.3	190.47	227.54
Common Stock	10.93	10.93	11.01	11.01	11.01	11.01
Additional Paid-In Capital	45.91	59.86	71.28	71.28	71.28	71.28
Retained Earnings	188.43	168.38	142.22	156.51	121.29	41.87
Treasury Stock	-43.75	-30.83	-31.09	-15.87	-25.68	-21.45
Comprehensive Income & Other	0.01	0.02	0.02	0.02	0.02	0.01
Total Common Equity	201.53	208.36	193.44	222.96	177.92	102.72
Shareholders' Equity	201.53	208.36	193.44	222.96	177.92	102.72
Total Liabilities & Equity	348.25	349.64	340.52	393.26	368.39	330.26
Total Debt	51.4	51.08	43.67	42.63	49.33	56.67
Net Cash (Debt)	76.68	103.45	118.89	139.79	152.55	138.85
Net Cash Growth	-19.93%	-12.99%	-14.95%	-8.36%	9.86%	-
Net Cash Per Share	-	5.89	6.64	7.74	8.44	7.58
Filing Date Shares Outstanding	-	17.57	17.64	18.11	18.01	18.11
Total Common Shares Outstanding	-	17.57	17.64	18.11	18.01	18.11
Working Capital	161.62	167.55	156.71	177.86	208.89	150.73
Book Value Per Share	-	11.86	10.97	12.31	9.88	5.67
Tangible Book Value	200.41	207.36	192.2	221.77	176.79	101.74
Tangible Book Value Per Share	-	11.80	10.90	12.25	9.82	5.62
Land	-	36.04	29.04	29.04	22.59	21.99
Machinery	-	60.68	43.28	27.87	24.32	21.51

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.